Contour Neurovascular System for endovascular embolization of cerebral aneurysms: a multicenter cohort study of 10 European neurovascular centers.

Aneurysm Device Flow Diverter

Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
17 May 2024
Historique:
received: 14 02 2024
accepted: 28 04 2024
medline: 18 5 2024
pubmed: 18 5 2024
entrez: 17 5 2024
Statut: aheadofprint

Résumé

Intrasaccular devices have become increasingly popular in the treatment of cerebral aneurysms, particularly at the bifurcation. Here we evaluate the Contour Neurovascular System, an intrasaccular device for the endovascular treatment of cerebral aneurysms, in a multicenter cohort study, the largest to the best of our knowledge. Consecutive patients with intracranial aneurysms treated with the Contour Neurovascular System between February 2017 and October 2022 at 10 European neurovascular centers were prospectively collected and retrospectively reviewed. Patient and aneurysm characteristics, procedural details, and angiographic and clinical outcomes were evaluated. During the study period, 279 aneurysms (median age of patients 60 years, IQR 52-68) were treated with Contour. In 83.2% of patients the device was placed electively, whereas the remaining patients were treated in the setting of acute subarachnoid hemorrhage. The most common locations were the middle cerebral artery (26.5%) followed by the anterior communicating region (26.2%). Median aneurysm dome and neck size were 5.2 mm (IQR 4.2-7) and 3.9 mm (IQR 3-5). Contour size 7 (39%) and 9 (25%) were most used. Thromboembolic and hemorrhagic complications occurred in 6.8% and 0.4% of aneurysms, respectively. Raymond-Roy 1 and 2 occlusions at last follow-up were achieved in 63.2% and 28.3%, respectively, resulting in adequate occlusion of 91.5% of aneurysms. This is the largest multicenter study reporting the outcome on the Contour Neurovascular System. At 1 year, the self-evaluated data on safety and efficacy are comparable to data of existing intrasaccular devices. Contour is a promising technology in the treatment of cerebral aneurysms.

Sections du résumé

BACKGROUND BACKGROUND
Intrasaccular devices have become increasingly popular in the treatment of cerebral aneurysms, particularly at the bifurcation. Here we evaluate the Contour Neurovascular System, an intrasaccular device for the endovascular treatment of cerebral aneurysms, in a multicenter cohort study, the largest to the best of our knowledge.
METHODS METHODS
Consecutive patients with intracranial aneurysms treated with the Contour Neurovascular System between February 2017 and October 2022 at 10 European neurovascular centers were prospectively collected and retrospectively reviewed. Patient and aneurysm characteristics, procedural details, and angiographic and clinical outcomes were evaluated.
RESULTS RESULTS
During the study period, 279 aneurysms (median age of patients 60 years, IQR 52-68) were treated with Contour. In 83.2% of patients the device was placed electively, whereas the remaining patients were treated in the setting of acute subarachnoid hemorrhage. The most common locations were the middle cerebral artery (26.5%) followed by the anterior communicating region (26.2%). Median aneurysm dome and neck size were 5.2 mm (IQR 4.2-7) and 3.9 mm (IQR 3-5). Contour size 7 (39%) and 9 (25%) were most used. Thromboembolic and hemorrhagic complications occurred in 6.8% and 0.4% of aneurysms, respectively. Raymond-Roy 1 and 2 occlusions at last follow-up were achieved in 63.2% and 28.3%, respectively, resulting in adequate occlusion of 91.5% of aneurysms.
CONCLUSION CONCLUSIONS
This is the largest multicenter study reporting the outcome on the Contour Neurovascular System. At 1 year, the self-evaluated data on safety and efficacy are comparable to data of existing intrasaccular devices. Contour is a promising technology in the treatment of cerebral aneurysms.

Identifiants

pubmed: 38760167
pii: jnis-2023-021378
doi: 10.1136/jnis-2023-021378
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: Please see uploaded ICMJE forms from co-authors.

Auteurs

Christoph J Griessenauer (CJ)

Department of Neurosurgery, Christian Doppler Clinic, Paracelsus Medical University, Salzburg, Austria christoph.griessenauer@gmail.com.

Sherief Ghozy (S)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.

Alessandra Biondi (A)

Department of Interventional Neuroradiology, Besançon University Hospital, Besançon, France.
Laboratoire de Recherches Intégratives en Neurosciences et Psychologie Cognitive - UR 481 LINC, Université Franche-Comté, Besançon, France.

Constantin Hecker (C)

Department of Neurosurgery, Christian Doppler Clinic, Paracelsus Medical University, Salzburg, Austria.
Institute of Neurointervention, Paracelsus Medical University Salzburg, Salzburg, Austria.

Fritz Wodarg (F)

Department of Radiology and Neuroradiology, University Medical Center Schleswig-Holstein, Kiel, Germany.

Thomas Liebig (T)

Department of Neuroradiology, University Hospital Munich (LMU), Munich, Germany.

Tufail Patankar (T)

Department of Neuroradiology, Leeds General Infirmary, Leeds, UK.

Saleh Lamin (S)

Diagnostic and Interventional Neuroradiology, University Hospital Birmingham, Queen Elizabeth, Birmingham, UK.

Mario Martínez-Galdámez (M)

Interventional Neuroradiology/Endovascular Neurosurgery, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Department of Radiology and Interventional Neuroradiology, Hospital La Luz, Quironsalud, Madrid, Spain.

Christophe Cognard (C)

Department of Neuroradiology, Hôpital Purpan, Toulouse, France.

Jens Fiehler (J)

Department of Neuroradiology, University Medical Center Hamburg Eppendorf, Hamburg, Germany.

Franziska Dorn (F)

Department of Neuroradiology, University of Bonn, Bonn, Germany.

Adam A Dmytriw (AA)

Neuroendovascular Program, Massachusetts General Hospital, Boston, Massachusetts, USA.
Neuroradiology & Neurointervention, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Monika Killer-Oberpfalzer (M)

Institute of Neurointervention, Paracelsus Medical University Salzburg, Salzburg, Austria.
Department of Neurology, Christian Doppler Clinic, Paracelsus Medical University, Salzburg, Austria.

Classifications MeSH